Reichenberg S et al., 2015-04-20: Spike-recovery study of the full THERAFLEX MB-Plasma process (leucocyte filtration, methylene blue/light, MB removal filter) in plasma: virus inactivation held even in lipaemic plasma, but most bacterial kill came from the leucocyte filter rather than from the methylene blue step.
Leucocyte filtration alone efficiently eliminated most of the tested bacteria by more than 4 logs (Staphylococcus epidermidis and Staphylococcus aureus) or to the limit of detection (LOD) (≥ 4.8 logs; Escherichia coli, Bacillus cereus and Klebsiella pneumoniae).
Abstract
Reichenberg S et al., 2015-04-20: Spike-recovery study of the full THERAFLEX MB-Plasma process (leucocyte filtration, methylene blue/light, MB removal filter) in plasma: virus inactivation held even in lipaemic plasma, but most bacterial kill came from the leucocyte filter rather than from the methylene blue step. Study type: in vitro spiking/challenge study on plasma units (no human subjects). Country: Germany (German Red Cross Blood Service NSTOB and Macopharma). Organisms: S. epidermidis, S. aureus, E. coli, B. cereus, K. pneumoniae, Brevundimonas diminuta; viruses: suid herpesvirus 1, bovine viral diarrhoea virus, HIV-1. MB/light parameters not given in abstract (full text: 1 ug/mL MB, 630 nm, standard light dose). Funding/COI not in the retrieved abstract record. Reading: this is the honest boundary of the system , it is a virus-reduction method that happens to be bactericidal mostly because of the filter. Study type: lab.
